13F Data
13F filer · CIK 1404574

683 Capital Management, LLC

NEW YORK, NY · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$2.0B
+$120.2M vs prior
Positions
153
New / sold out
23 / 107
Added / reduced
33 / 45
Turnover
20.3%
buys $401.2M · sells $406.8M
Top-10 weight
47.3%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewSPDR SERIES TRUSTPUT+540,000–+$85.5M
NewABBVIE INCPUT+245,000–+$61.7M
AddedCARVANA CO+595,000+383.9%+$39.2M
AddedLLYELI LILLY & COPUT+20,000+14.9%+$24.0M
NewUNITY SOFTWARE INC+615,000–+$17.6M
AddedARK ETF TRPUT+400,000+114.3%+$16.8M
NewFIRST TRACKS BIOTHERAPEUTICS+750,000–+$15.1M
NewSEA LTD+135,000–+$12.9M
AddedPALANTIR TECHNOLOGIES INCPUT+100,000+4.3%+$11.7M
NewHARMONY BIOSCIENCES HLDGS IN+294,000–+$10.7M
46 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedUNIQURE NVCALL-937,400-74.8%$-43.2M
Sold outTESLA INCPUT-110,000-100.0%$-40.9M
ReducedASTRANA HEALTH INC-490,000-70.0%$-22.7M
ReducedGXO LOGISTICS INCORPORATED-285,000-57.0%$-14.4M
Sold outLLYELI LILLY & CO-15,000-100.0%$-13.8M
Sold outAMICUS THERAPEUTIC-775,000-100.0%$-11.2M
ReducedTG THERAPEUTICS INC-200,919-34.1%$-11.0M
Sold outGOSSAMER BIO INC-27,877,000-100.0%$-10.6M
Sold outAPELLIS PHARMACEUTICALS INC-250,000-100.0%$-10.1M
Sold outLENNAR CORP-115,000-100.0%$-9.7M
142 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $299.2MQ3 2013: $393.9MQ4 2013: $349.9MQ1 2014: $256.7MQ2 2014: $264.6MQ3 2014: $293.0MQ4 2014: $228.1MQ1 2015: $262.6MQ2 2015: $482.0MQ3 2015: $679.8MQ4 2015: $730.4MQ1 2016: $560.8MQ2 2016: $627.2MQ3 2016: $941.7MQ4 2016: $1.4BQ1 2017: $643.6MQ2 2017: $678.8MQ3 2017: $951.6MQ4 2017: $1.2BQ1 2018: $1.1BQ2 2018: $1.5BQ3 2018: $1.5BQ4 2018: $1.7BQ1 2019: $1.1BQ2 2019: $1.1BQ3 2019: $899.3MQ4 2019: $874.3MQ1 2020: $852.6MQ2 2020: $1.2BQ3 2020: $1.4BQ4 2020: $2.1BQ1 2021: $1.9BQ2 2021: $2.9BQ3 2021: $2.6BQ4 2021: $2.7BQ1 2022: $1.9BQ2 2022: $1.4BQ3 2022: $1.3BQ4 2022: $1.2BQ1 2023: $1.3BQ2 2023: $1.4BQ3 2023: $1.3BQ4 2023: $1.2BQ1 2024: $1.4BQ2 2024: $1.3BQ3 2024: $1.3BQ4 2024: $1.6BQ1 2025: $1.4BQ2 2025: $1.5BQ3 2025: $1.9BQ4 2025: $2.3BQ1 2026: $1.9BQ2 2026: $2.0B
Q2 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1PALANTIR TECHNOLOGIES INCPUTCL A2,428,700$283.4M13.91%
2LLYELI LILLY & COPUT154,000$184.7M9.07%
3NVIDIA CORPORATIONPUTCOM456,000$91.2M4.48%
4SPDR SERIES TRUSTPUTST STR SP BIOT540,000$85.5M4.20%
5CAPITAL ONE FINL CORPCOM365,000$73.2M3.60%
6ABBVIE INCPUTCOM245,000$61.7M3.03%
7CARVANA COCL A750,000$49.4M2.42%
8MADRIGAL PHARMACEUTICALS INCPUTCOM90,000$48.3M2.37%
9ANAPTYSBIO INCCOM660,000$44.6M2.19%
10KASPI KZ JSCSPONSORED ADS470,000$40.7M2.00%
143 more rows. Subscribe for $29/month to see every row, download the data and use the API.